Status:
TERMINATED
Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus
Lead Sponsor:
Emory University
Conditions:
Esophageal Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.
Detailed Description
This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered ...
Eligibility Criteria
Inclusion
- Measurable disease with resectable local-regional carcinoma of the esophagus. 18 years of age or older.
Exclusion
- Pregnant or lactating. Non-resectable local-regional carcinoma of the esophagus.
Key Trial Info
Start Date :
January 1 1996
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00208936
Start Date
January 1 1996
Last Update
September 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Winship Cancer Institute
Atlanta, Georgia, United States, 30322